Philippe Langella mainly focuses on Microbiology, Immunology, Dysbiosis, Faecalibacterium prausnitzii and Colitis. His Microbiology research is multidisciplinary, incorporating elements of Gut flora, Lactococcus lactis, Inflammatory bowel disease, Immune system and Bacteria. His Immunology study incorporates themes from Probiotic, Ovarian cancer and Intestinal mucosa.
As a part of the same scientific study, Philippe Langella usually deals with the Probiotic, concentrating on Firmicutes and frequently concerns with Peripheral blood mononuclear cell. His Faecalibacterium prausnitzii research incorporates elements of Acute colitis, Human microbiome and In vivo. His biological study deals with issues like Interleukin 10, which deal with fields such as Chemokine, Elafin, Ovalbumin and T cell.
His main research concerns Microbiology, Lactococcus lactis, Immunology, Bacteria and Probiotic. His research integrates issues of Dysbiosis, Colitis, Immune system and Lactobacillus in his study of Microbiology. Philippe Langella has researched Lactococcus lactis in several fields, including Plasmid, Recombinant DNA, Biochemistry, Antigen and Molecular biology.
His Recombinant DNA study combines topics in areas such as Fibronectin binding protein A and In vivo. His Immunology research is multidisciplinary, incorporating perspectives in Intestinal mucosa and Inflammatory bowel disease. The Faecalibacterium prausnitzii study combines topics in areas such as Crohn's disease, Internal medicine, Anti-inflammatory and Gastroenterology.
Philippe Langella mainly investigates Microbiology, Probiotic, Gut flora, Immunology and Lactococcus lactis. The various areas that Philippe Langella examines in his Microbiology study include Colitis, Bacteria, Biofilm, Immune system and Escherichia coli. His research in Probiotic intersects with topics in Commensalism, Biotechnology and In vitro.
Many of his research projects under Gut flora are closely connected to Aryl hydrocarbon receptor with Aryl hydrocarbon receptor, tying the diverse disciplines of science together. His research in Immunology focuses on subjects like Inflammatory bowel disease, which are connected to Intestinal mucosa. His Lactococcus lactis research integrates issues from Plasmid, Bifidobacterium longum and Recombinant DNA.
The scientist’s investigation covers issues in Microbiology, Dysbiosis, Bacteria, Gut flora and Probiotic. His Microbiology study combines topics from a wide range of disciplines, such as Immune system, Colitis, Immunology, Lactococcus lactis and Saccharomyces boulardii. In his research on the topic of Immune system, Faecalibacterium prausnitzii is strongly related with NF-κB.
His Immunology study focuses on Inflammation in particular. Philippe Langella combines subjects such as Butyrate and Gastrointestinal Microbiome with his study of Bacteria. His Gut flora research is multidisciplinary, relying on both Endocrinology, Internal medicine, Metabolic syndrome, Lactobacillus rhamnosus and Pharmacology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients
Harry Sokol;Bénédicte Pigneur;Laurie Watterlot;Omar Lakhdari.
Proceedings of the National Academy of Sciences of the United States of America (2008)
Microbial dysbiosis in colorectal cancer (CRC) patients.
Iradj Sobhani;Julien Tap;Françoise Roudot-Thoraval;Jean P. Roperch.
PLOS ONE (2011)
Faecalibacterium prausnitzii and human intestinal health
S. Miquel;R. Martin;R. Martin;O. Rossi;L.G. Bermudez-Humaran;L.G. Bermudez-Humaran.
Current Opinion in Microbiology (2013)
Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes: molecular mechanisms and probiotic treatment
Jacques Amar;Chantal Chabo;Aurelie Waget;Pascale Klopp.
Embo Molecular Medicine (2011)
Two plasmid-determined restriction and modification systems in Streptococcus lactis.
Alain Chopin;Marie-Christine Chopin;Agnès Moillo-Batt;Philippe Langella.
Fungal microbiota dysbiosis in IBD
Harry Sokol;Valentin Leducq;Hugues Aschard;Hang-Phuong Pham.
Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases
Henri Duboc;Henri Duboc;Sylvie Rajca;Sylvie Rajca;Dominique Rainteau;Dominique Rainteau;David Benarous.
CARD9 impacts colitis by altering gut microbiota metabolism of tryptophan into aryl hydrocarbon receptor ligands
Bruno Lamas;Mathias L Richard;Valentin Leducq;Hang-Phuong Pham.
Nature Medicine (2016)
Identification of an anti-inflammatory protein from Faecalibacterium prausnitzii, a commensal bacterium deficient in Crohn’s disease
E. Quévrain;E. Quévrain;M.A. Maubert;C. Michon;C. Michon;F. Chain;F. Chain.
Enterococcus hirae and Barnesiella intestinihominis Facilitate Cyclophosphamide-Induced Therapeutic Immunomodulatory Effects
Romain Daillère;Romain Daillère;Romain Daillère;Marie Vétizou;Marie Vétizou;Marie Vétizou;Nadine Waldschmitt;Takahiro Yamazaki;Takahiro Yamazaki.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: